FDA grants accelerated approval to Alzheimer's drug that appears to slow cognitive decline
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
from CNN.com - RSS Channel - US https://ift.tt/O8qgNo6
via IFTTT
from CNN.com - RSS Channel - US https://ift.tt/O8qgNo6
via IFTTT
Comments
Post a Comment
Thanks